This is a review about Smad1, based on 21 published articles (read how Labome selects the articles), using Smad1 antibody in all methods. It is aimed to help Labome visitors find the most suited Smad1 antibody.
Smad1 synonym: BSP-1; BSP1; JV4-1; JV41; MADH1; MADR1; MAD homolog 1; MAD, mothers against decapentaplegic homolog 1; Mad-related protein 1; SMAD, mothers against DPP homolog 1; TGF-beta signaling protein 1; mothers against DPP homolog 1; mothers against decapentaplegic homolog 1; transforming growth factor-beta signaling protein 1; transforming growth factor-beta-signaling protein 1

Cell Signaling TechnologyCell Signaling Technology Smad1 product
  • immunocytochemistryIn 2008, W K K Wu et al. employed Cell Signaling Technology Smad1 antibody to elucidate the anti-mitogenic effect of a proteasome inhibitor in relation to BMP signalling in colon cancer [ncbi , more ].
  • immunohistochemistryIn 2007, Lanying Song et al. utilized Cell Signaling Technology Smad1 antibody to study the role of Alk3 during AV cushion morphogenesis in mouse embryonic hearts [ncbi , more ]. In 2005, Tatsuya Kobayashi et al. applied Cell Signaling Technology Smad1 antibody to study the mechanisms by which BMP signaling stimulates cellular differentiation during cartilage development [ncbi , more ].
  • western blotCell Signaling Technology Smad1 antibody was applied in 2009 to perform western blot in order to study the mechanism of the epithelial-mesenchymal transition in human mammary carcinoma cells induced by Six1 homeoprotein [ncbi , more ], to carry out western blot analysis in order to investigate the role for Smurf2 in promoting breast cancer metastasis [ncbi , more ]and to investigate the role of BMP9 signalling via ALK2/Smad1/Smad4 pathway in ovarian cancer [ncbi , more ]. Cell Signaling Technology Smad1 antibody was used in 2008 to elucidate the anti-mitogenic effect of a proteasome inhibitor in relation to BMP signalling in colon cancer [ncbi , more ], to perform western blot in order to show the mechanism that two functions of TGF become un-coupled during cancer development [ncbi , more ], to investigate SOSTDC1 expression in normal human kidney cells and clear cell renal carcinoma [ncbi , more ]and to perform western blot in order to study the role of Smurf1 in TNF-induced systemic bone loss [ncbi , more ]. In 2005, Kosei Ijiri et al. utilized Cell Signaling Technology Smad1 antibody to study GADD45 beta role during chondrocyte terminal differentiation [ncbi , more ]. Daniel Besser et al. utilized Cell Signaling Technology Smad1 antibody to study expression of nodal, lefty-A, and lefty-B in undifferentiated human embryonic stem cells [ncbi , more ] in 2004 and Hiroaki Seto et al. used Cell Signaling Technology Smad1 antibody to detect phospho-Smad1 in human fibroblastic cells infected with recombinant adenovirus vectors carrying ALK3CA, ALK5CA, and ALK6CA [ncbi , more ].
EMD MilliporeEMD Millipore Smad1 product
  • western blotIn 2009, Blanca Herrera et al. used EMD Millipore Smad1 antibody to investigate the role of BMP9 signalling via ALK2/Smad1/Smad4 pathway in ovarian cancer [ncbi , more ]. In 2007, Weibin Shi et al. utilized EMD Millipore Smad1 antibody to study endofin as a Smad anchor for receptor activation in BMP signaling [ncbi , more ]. In 2004, Daniel Besser et al. utilized EMD Millipore Smad1 antibody to study expression of nodal, lefty-A, and lefty-B in undifferentiated human embryonic stem cells [ncbi , more ]. In 2003, Jun Harada et al. used EMD Millipore Smad1 antibody to study the requirement of the co-repressor homeodomain-interacting protein kinase 2 (HIPK2) for Ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation [ncbi , more ]. In 2002, Amina F Zebboudj et al. used EMD Millipore Smad1 antibody to characterize matrix GLA protein [ncbi , more ].
Life Technologies CorporationLife Technologies Corporation Smad1 product
  • western blotIn 2009, Blanca Herrera et al. used Life Technologies Corporation Smad1 antibody to investigate the role of BMP9 signalling via ALK2/Smad1/Smad4 pathway in ovarian cancer [ncbi , more ].
EpitomicsEpitomics Smad1 product
  • western blotIn 2009, Chaoyang Jin et al. utilized Epitomics Smad1 antibody to carry out western blot analysis in order to investigate the role for Smurf2 in promoting breast cancer metastasis [ncbi , more ].
AbcamAbcam Smad1 product
  • western blotIn 2009, Jason T Huse et al. applied Abcam Smad1 antibody to study the mechanism for PTEN regulation in glioma and further highlight dysregulation of Akt signaling as crucial to the development of these tumors [ncbi , more ].
Santa Cruz BiotechnologySanta Cruz Biotechnology Smad1 product
  • immunocytochemistryIn 2010, Tanja Vogel et al. applied Santa Cruz Biotechnology Smad1 antibody to carry out immunofluorescence assays in order to investigate the role for transforming growth factor beta in regulating neuronal cell development [ncbi , more ]. In 2005, Constance E Runyan et al. used Santa Cruz Biotechnology Smad1 antibody to study the role of internalization in transforming growth factor beta 1-induced smad2 association with smad anchor for receptor activation (SARA) and smad2-dependent signaling in human mesangial cells [ncbi , more ].
  • immunoprecipitationSanta Cruz Biotechnology Smad1 antibody was used in 2003 to demonstrate that continued nucleocytoplasmic shuttling is a common requisite for the active signaling of R-Smads [ncbi , more ], to study the differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis [ncbi , more ]and to study the requirement of the co-repressor homeodomain-interacting protein kinase 2 (HIPK2) for Ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation [ncbi , more ].
  • western blotIn 2008, Ruolin Guo et al. employed Santa Cruz Biotechnology Smad1 antibody to perform western blot in order to study the role of Smurf1 in TNF-induced systemic bone loss [ncbi , more ]. Weibin Shi et al. utilized Santa Cruz Biotechnology Smad1 antibody to study endofin as a Smad anchor for receptor activation in BMP signaling [ncbi , more ] in 2007 and Norman G Nagl et al. used Santa Cruz Biotechnology Smad1 antibody to demonstrate the opposing roles of distinct mammalian SWI/SNF chromatin remodeling complexes in cell-cycle control [ncbi , more ]. In 2003, Kenji Hata et al. applied Santa Cruz Biotechnology Smad1 antibody to study the differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis [ncbi , more ].
Articles Reviewed
  1. Blanca Herrera et al. (2009). "Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation".PMID 19996292
  2. Douglas S Micalizzi et al. (2009). "The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling".PMID 19726885
  3. Tanja Vogel et al. (2010). "Transforming growth factor beta promotes neuronal cell fate of mouse cortical and hippocampal progenitors in vitro and in vivo: identification of Nedd9 as an essential signaling component".PMID 19587023
  4. Jason T Huse et al. (2009). "The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo".PMID 19487573
  5. Chaoyang Jin et al. (2009). "Smad ubiquitination regulatory factor 2 promotes metastasis of breast cancer cells by enhancing migration and invasiveness".PMID 19155312
  6. Ruolin Guo et al. (2008). "Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins".PMID 18567580
  7. W K K Wu et al. (2008). "Bone morphogenetic protein signalling is required for the anti-mitogenic effect of the proteasome inhibitor MG-132 on colon cancer cells".PMID 18414391
  8. Savita Bharathy et al. (2008). "Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype".PMID 18339844
  9. Kimberly Rose Blish et al. (2008). "A human bone morphogenetic protein antagonist is down-regulated in renal cancer".PMID 18032587
  10. Weibin Shi et al. (2007). "Endofin acts as a Smad anchor for receptor activation in BMP signaling".PMID 17356069
  11. Norman G Nagl et al. (2007). "Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control".PMID 17255939
  12. Lanying Song et al. (2007). "Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts".PMID 16959237
  13. Tatsuya Kobayashi et al. (2005). "BMP signaling stimulates cellular differentiation at multiple steps during cartilage development".PMID 16322106
  14. Kosei Ijiri et al. (2005). "A novel role for GADD45beta as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation".PMID 16144844
  15. Constance E Runyan et al. (2005). "The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells".PMID 15613484
  16. Daniel Besser et al. (2004). "Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3".PMID 15308665
  17. Hiroaki Seto et al. (2004). "Distinct roles of Smad pathways and p38 pathways in cartilage-specific gene expression in synovial fibroblasts".PMID 14991070
  18. Jun Harada et al. (2003). "Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation".PMID 12874272
  19. Zhan Xiao et al. (2003). "A novel nuclear export signal in Smad1 is essential for its signaling activity".PMID 12821673
  20. Kenji Hata et al. (2003). "Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis".PMID 12589053
  21. Amina F Zebboudj et al. (2002). "Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2".PMID 11741887